Tocqueville Asset Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-79,000
| Closed | -$23.3K | – | 545 |
|
|
2023
Q3 | $23.3K | Hold |
79,000
| – | – | ﹤0.01% | 507 |
|
|
2023
Q2 | $38.1K | Hold |
79,000
| – | – | ﹤0.01% | 530 |
|
|
2023
Q1 | $49.7K | Hold |
79,000
| – | – | ﹤0.01% | 522 |
|
|
2022
Q4 | $37.1K | Sell |
79,000
-38,500
| -33% | -$18.1K | ﹤0.01% | 572 |
|
|
2022
Q3 | $97K | Buy |
117,500
+4,500
| +4% | +$3.72K | ﹤0.01% | 582 |
|
|
2022
Q2 | $132K | Buy |
113,000
+25,000
| +28% | +$29.2K | ﹤0.01% | 643 |
|
|
2022
Q1 | $112K | Hold |
88,000
| – | – | ﹤0.01% | 691 |
|
|
2021
Q4 | $143K | Sell |
88,000
-5,000
| -5% | -$8.13K | ﹤0.01% | 722 |
|
|
2021
Q3 | $258K | Sell |
93,000
-4,700
| -5% | -$13K | ﹤0.01% | 657 |
|
|
2021
Q2 | $294K | Buy |
97,700
+5,100
| +6% | +$15.3K | ﹤0.01% | 641 |
|
|
2021
Q1 | $378K | Hold |
92,600
| – | – | 0.01% | 600 |
|
|
2020
Q4 | $433K | Buy |
92,600
+27,700
| +43% | +$130K | 0.01% | 563 |
|
|
2020
Q3 | $269K | Buy |
64,900
+10,000
| +18% | +$41.4K | 0.01% | 588 |
|
|
2020
Q2 | $199K | Buy |
+54,900
| New | +$199K | ﹤0.01% | 627 |
|